Former consumer goods distribution, food, and retail service industry executive will help guide the Company’s global expansion initiatives ...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients ...

Wednesday that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare ...

Chaim Lebovits; President, Chief Executive Officer; Brainstorm Cell Therapeutics Inc. Alla Patlis; Interim Chief ...

WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin ...

The company has a dedicated team of more than 300 staff working in its state-of-the-art R&D and GMP manufacturing facilities in Nijmegen, the Netherlands. For more information visit www.byondis.com.

ViroCell Biologics ("ViroCell" or the "Company"), a cell and gene therapy ("CGT") contract development and manufacturing organization ("CDMO") specializing in GMP viral vector manufacturing for ...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Christoph Korpus, PhD, MBA, as ...

All these experiences will be invaluable as our company looks ahead to a year of important milestones," said Jason Meyenburg, Chief Executive Officer of ... join the Auregen team on a permanent ...

Q4 2024 Earnings Call Transcript March 31, 2025 Brainstorm Cell Therapeutics Inc. reports earnings inline with expectations.